MIRA Pharmaceuticals, Inc. (MIRA) Financials

$1.10

south_east
-$0.01 (-0.9%)
Day's range
$1.1
Day's range
$1.13
$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8M-$10M-$10M-$12M-$12MEarning202020202021202120222022202320236%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MIRA Income statement / Annual

Last year (2023), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, MIRA Pharmaceuticals, Inc.'s net income was -$11.98 M. See MIRA Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $8.53 M $0.00 $0.00 $0.00
Gross Profit -$8.53 M $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $1.57 M $2.35 M $684,447.00 $14,647.00
General & Administrative Expenses $6.50 M $2.99 M $770,115.00 $158,946.00
Selling & Marketing Expenses $453,550.00 $0.00 $0.00 $52,823.00
Selling, General & Administrative Expenses $6.95 M $2.99 M $770,115.00 $52,982.00
Other Expenses $0.00 -$1.70 M -$697,600.00 $0.00
Operating Expenses $8.53 M $7.05 M $2.15 M $67,629.00
Cost And Expenses $8.53 M $7.05 M $2.15 M $67,629.00
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $3.46 M $10,250.00 $24,374.00 $364.00
Depreciation & Amortization $8.53 M $7.05 M $2.15 M $202,887.00
EBITDA $0.00 -$7.05 M -$2.15 M $0.00
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net -$3.46 M -$10,250.00 -$24,374.00 $134,894.00
Income Before Tax -$11.98 M -$7.06 M -$2.18 M -$67,993.00
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 -$7,047.94 -$2,152.16 -$202.89
Net Income -$11.98 M -$7.06 M -$2.18 M -$67,993.00
Net Income Ratio 0 0 0 0
EPS -0.65 -0.48 -0.15 -0.0046
EPS Diluted -0.65 -0.48 -0.15 -0.0046
Weighted Average Shares Out $18.57 M $14.75 M $14.75 M $14.75 M
Weighted Average Shares Out Diluted $18.57 M $14.75 M $14.75 M $14.75 M
Link